This is in contrast to PC in which high PSMA expression is correlated with prostate-specific antigen (PSA) recurrence and other prognostic factors which negatively affect survival such as tumour grade, pathological stage and castration resistance [4, 24]. This evidence concerns the gene FOLH1 and pachyonychia congenita.